semaglutide and the liver weight-loss-independent hepatoprotective benefits of are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors Semaglutide Improves Liver Steatosis and

The market is shaped by high obesity prevalence-over 100 million adults, coupled with reimbursement complexity across Medicare, Medicaid, and commercial plans [1]

The most commonly reported side effects are those that stem from their action with the digestive system

Both rates remain acceptable and significantly lower than many older weight loss medications

Despite the substantial evidence and promising hypotheses, further research and clinical investigations are necessary to fully understand the role of polyphenols and establish them as advanced therapeutic targets for age-related neurodegenerative diseases and neuroinflammatory conditions